Login

Christoph Vilanek is the CEO of Freenet. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Clarksons Platou Merger: A Game-Changer in Maritime Innovation | Andi Case - Chief Executive Officer of Clarkson plc
00:10:00
Invest specifically in emerging consumer brands|Kiva Dickinson,Co-Founder and Managing Partner,Selva Ventures
00:10:00
Radiopharmaceutical Innovations in Cancer Diagnosis |Dr Alan Taylor , Executive Chairma, Clarity Pharmaceuticals Ltd.
00:10:00
Internship Strategies: Early Steps to Career Success
00:10:00
Lomiko Metals: Building North America’s Largest Undeveloped Graphite Asset with Non-Dilutive Government Backing|Gordana Slepcev,CEO,Lomiko Metals Inc
00:10:00
Mike Gianoni Presents Blackbaud's 2020 Social Responsibility Report | Mike Gianoni, CEO, Blackbaud Inc.
00:10:00
signifying leadership within a VC firm, overseeing investment decisions and firm strategy.|Amy Saper,Partner,Accel
00:10:00
William "Bill" Nuti, CEO of NCR Corp., discusses the company's third-quarter performance.|Michael D. Hayford Retiring as NCR Chief Executive Officer
00:10:00
Pinnacle West CEO Jeff Guldner discusses the journey towards a zero carbon future | Jeffrey B. Guldner, CEO , Pinnacle West Capital Corp.
00:10:00
Leadership Spotlight Series with Kim Salem-Jackson: Meet Kate Prouty | Alex P Shootman, CEO, Alkami Technology IncALKT:NSQ
00:10:00
The Inheritance Playbook: Navigating Wealth Transfer and Tax Efficiency | Chad Holmes, CEO, Formula Wealth
00:10:00
Market Volatility and Oil Price Impact: What Investors Need to Know

© 2017 - Neuhu+